Lv4
590 积分 2025-03-03 加入
Befotertinib: First Approval
4个月前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
4个月前
已完结
The characterization of two specific drug binding sites on human serum albumin
4个月前
已完结
皖公网安备34019202002308
